Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - SHORT-TERM DEBT
Short-term Debt KYMR - Kymera Therapeutics, Inc.
6.34 M
LAST VALUE
-6.11%
2 YEAR CAGR
83.86%
5 YEAR CAGR
0.00%
10 YEAR CAGR